Download biomedica product listTuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is a global health problem. At present, prior exposure to Mtb can be determined by blood-based interferon-gamma release assay (IGRA), but active TB is not always detectable by blood tests.
Leucine-rich alpha-2 glycoprotein (LRG), a new inflammatory biomarker, and has been shown that it could be a promising biomarker when performed following IGRA for the detection of active TB.
Learn more: https://www.nature.com/articles/s41598-020-60450-3
Did you know?
LRG can reliably be measured by ELISA in human serum, plasma and urine samples with Biomedica’s fully validated assay kit. https://www.bmgrp.com/product/cardiovascular/leucine-rich-alpha-2-glycoprotein-lrg-elisa-bi-lrg/
√ CONVENIENT – Assay range optimized for clinical samples;
– Ready to use standards and 2 controls included
√ RELIABLE – Rigorously validated according to FDA/EMEA/ICH guidelines
√ SPECIFIC – Characterized, epitope mapped capture and detection antibodies
√ QUALIFIED CUSTOMER SERVICE – supports you every step of the way
√ HIGH QUALITY GUARANTEED